文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

终末期肾病患者的急诊评估与管理

Emergency medicine evaluation and management of the end stage renal disease patient.
PubMed 文献 · Am J Emerg Med · 2017-09-05
一句话结论综述指出终末期肾病患者需关注心、脑、感染及透析通路并发症,并调整镇痛、镇静、抗菌及抗凝药物剂量。

本文为综述,针对美国发病率上升的终末期肾病(ESRD)患者,评估其心、脑、感染、血管及透析通路相关并发症,以及药物使用注意事项。ESRD患者需肾脏替代治疗,包括血液透析或腹膜透析,各有特定问题。患者神经、心肺、感染及通路并发症风险更高,且感染常表现不典型。急诊医生需结合肾脏生理及并发症特点进行评估和管理,并注意镇痛、镇静、肌松、抗菌及抗凝药物的特殊考虑。

要点

  • ESRD患者全因死亡、心血管事件及住院率高于肾功能正常者,急诊评估需关注多系统并发症。
  • 感染常见且表现不典型,通路部位感染和转移性感染必须积极治疗。
  • 通路并发症包括出血、动脉瘤/假性动脉瘤、血栓/狭窄及动脉盗血综合征,需急诊识别。
  • 心肺并发症包括心包炎、心包积液/填塞、急性冠脉综合征、心源性猝死、电解质异常、肺水肿及空气栓塞。
  • 药物使用需特殊考虑镇痛药、镇静药、神经肌肉阻滞剂、抗菌药及抗凝药。

适用人群与场景

  • 终末期肾病(ESRD)患者,包括接受血液透析(HDS)或腹膜透析(PD)者,在急诊科就诊时适用。

红旗征与不能漏的情况

  • 通路部位感染和转移性感染必须积极治疗。
  • 心包积液/填塞、急性冠脉综合征、心源性猝死、电解质异常、肺水肿及空气栓塞为需要紧急处理的心肺并发症。
  • 通路出血、动脉瘤/假性动脉瘤、血栓/狭窄及动脉盗血综合征需急诊识别和处理。

研究设计与关键结果

  • 综述指出ESRD发病率快速增加,患者需肾脏替代治疗(血液透析或腹膜透析),每种方式有特定特征。
  • ESRD患者神经并发症、心肺病理、感染及通路并发症风险更高,感染常表现不典型。
  • 重点病史和体格检查至关重要。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 急诊医生评估ESRD患者时应结合肾脏生理及并发症特点,注意感染不典型表现并积极治疗通路感染和转移性感染。
  • 对ESRD患者使用镇痛药、镇静药、神经肌肉阻滞剂、抗菌药及抗凝药时需特殊考虑。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: End stage renal disease (ESRD) is increasing in the U.S., and these patients demonstrate greater all-cause mortality, cardiovascular events, and hospitalization rates when compared to those with normal renal function. These patients may experience significant complications associated with loss of renal function and dialysis.

OBJECTIVE: This review evaluates complications of ESRD including cardiopulmonary, neurologic, infectious disease, vascular, and access site complications, as well as medication use in this population.

DISCUSSION: ESRD incidence is rapidly increasing, and patients commonly require renal replacement therapy including hemodialysis (HDS) or peritoneal dialysis (PD), each type with specific features. These patients possess greater risk of neurologic complications, cardiopulmonary pathology, infection, and access site complications. Focused history and physical examination are essential. Neurologic issues include uremic encephalopathy, cerebrovascular pathology, and several others. Cardiopulmonary complications include pericarditis, pericardial effusion/tamponade, acute coronary syndrome, sudden cardiac death, electrolyte abnormalities, pulmonary edema, and air embolism. Infections are common, with patients more commonly presenting in atypical fashion. Access site infections and metastatic infections must be treated aggressively. Access site complications include bleeding, aneurysm/pseudoaneurysm, thrombosis/stenosis, and arterial steal syndrome. Specific medication considerations are required for analgesics, sedatives, neuromuscular blocking agents, antimicrobials, and anticoagulants.

CONCLUSIONS: Consideration of renal physiology with complications in ESRD can assist emergency providers in the evaluation and management of these patients. ESRD affects many organ systems, and specific pharmacologic considerations are required.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Long B, Koyfman A, Lee CM, et al. Emergency medicine evaluation and management of the end stage renal disease patient. Am J Emerg Med. 2017. PMID: 28893450. doi:10.1016/j.ajem.2017.09.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。